The Oregon Translational Research and Drug Discovery Institute at Oregon State University was founded
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
OHSU’s Peter O Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill
In 2006, The OHSU Peter O. Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill in…
The National Cancer Institute approved a $10 million award for OHSU Cancer Institute
On Jul. 18, 2005, Oregon Health & Science University (OHSU) announced receipt of a five-year, $10 million award…
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
Pacific Northwest team unveiled the largest virus proteome to date
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
National Institutes of Health opened the Mark O Hatfield Clinical Research Center
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
The Schnitzer Investment Corporation donated nearly 20 acres of riverfront property in South Waterfront to OHSU
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
OHSU researcher uncovered macular degeneration gene
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
Molecular Probes was acquired by Invitrogen Corp
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
The Oregon Investment Fund was established
In Jul. 2003, HB 3613 was passed in the Oregon State Legislature and enacted a mandate for the…
OHSU broke ground on new biomedical research building
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
Oregon Health & Science University merged with Oregon Graduate Institute of Science and Technology
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
OHSU researchers produced the first genetically modified monkey
On Jan. 11, 2001, Oregon Health Sciences University (OHSU) researchers reported the production of the world’s first genetically…
The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
The Vaccine and Gene Therapy Institute and Neurological Sciences Institute buildings opened on OHSU’s west campus
In 2001, the Oregon Health & Science University (OHSU) Vaccine and Gene Therapy Institute and Neurological Sciences Institute…
Oregon Health Sciences Center’s name changed to Oregon Health & Science University
In 2001, Oregon Health Sciences Center’s name changed to Oregon Health & Science University (OHSU) as Governor John…
Biotechnology | Chemical | Environmental | EPA | NIH
OHSU received $11 million grant to fund new superfund research center
On Apr. 10, 2000, the Oregon Health Science Centers (OHSU) Center for Research on Occupational and Environmental Toxicology…
The Oregon College of Dentistry was founded in Portland
In 1998, The Oregon College of Dentistry was founded in Portland.
The Neurological Sciences Institute joined OHSU as its fifth research unit
In 1998, the Neurological Sciences Institute (NSI) joined the university as its fifth research unit. NSI researchers conduct…
Doernbecher Children’s Hospital’s new state-of-the-art pediatric medical complex was opened
In 1998, Doernbecher Children’s Hospital’s new state-of-the-art pediatric medical complex was opened. Built with private funding and bond…
The Mark O Hatfield Research Center was dedicated
In 1998, The Mark O. Hatfield Research Center was dedicated. The center houses a variety of basic and…
Planning began for the OHSU Center for Women’s Health
In 1997, planning began for Oregon Health & Science University’s (OHSU) Center for Women’s Health, and an interim…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The Oregon Cancer Center was established with a grant from the National Cancer Institute
In 1997, the Oregon Cancer Center was established with a grant from the National Cancer Institute (NCI) of…